NCT00226954 2020-03-18
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
Stanford University
Phase 2 Terminated
Clinical Trials
11 trialsNCT00582790 2019-11-25
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT02347163 2018-11-06
Pre-operative Zoledronate in Triple Negative Breast Cancer
Mario Negri Institute for Pharmacological Research
Phase 2 Terminated
NCT00265200 2018-03-05
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
University of Louisville
Phase 2 Terminated
NCT00889590 2016-01-26
HR-GCT
Leiden University Medical Center
Phase 2 Terminated
NCT00966992 2015-09-09
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT01067989 2015-07-08
Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
HaEmek Medical Center, Israel
Phase 2 Terminated
NCT01004510 2012-12-04
ZAP
Rochester General Hospital
Phase 2 Terminated
NCT00216151 2011-05-02
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma
Hoosier Cancer Research Network
Phase 2 Terminated
NCT00258765 2010-04-26
Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.
Novartis
Phase 2 Terminated
NCT00172068 2009-12-23
MRD-1
Novartis
Phase 2 Terminated